Circon board asks shareholders to defer decision on U.S. Surgical tender bid.
This article was originally published in The Gray Sheet
CIRCON ASKS SHAREHOLDERS TO DEFER DECISION ON U.S. SURGICAL OFFER "until they have been advised of Circon's position" on the unsolicited $18-per-share tender bid. In an Aug. 5 press release, Circon says its board of directors "is currently conferring with its financial and legal advisors" about the offer launched Aug. 2 ("The Gray Sheet" Aug. 5, p. 3) and will respond "in due course in accordance with its obligations under the securities laws."
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.